Synergy CHC Corp. 2025 Annual Report: Key Highlights and Investor Insights

Synergy CHC Corp. (Nasdaq: SNYR) has released its Annual Report for the fiscal year ended December 31, 2025. This comprehensive filing provides crucial insights into the company’s financial performance, operational strategies, risk factors, and outlook for investors. Here is an in-depth analysis of the report’s key points, focusing on matters potentially impacting shareholder value.

1. Financial Performance and Operations

• Net Income (Loss): The company reported a significant net loss of \$(12,341,208) for the year ended December 31, 2025, compared to a net income of \$2,124,976 the previous year. This dramatic shift is a critical point for investors, as it reflects new challenges or investments impacting short-term profitability.
• EBITDA: Synergy CHC uses EBITDA as a measure of core operational performance, calculated as net income plus interest, taxes, depreciation, and amortization. Investors should note EBITDA is highlighted as a useful indicator in addition to GAAP results.
• Operating Cash Flow: The company used \$2,585,022 in operating activities during 2025.
• Capital and Liquidity: As of December 31, 2025, Synergy CHC had a working capital surplus of \$1,778,308. The company raised an additional \$3.7 million in capital via a common stock offering and restructured its debt agreements, pushing maturities into 2029. An at-the-market (ATM) equity program is in place for further capital needs.

2. Strategic Growth Initiatives

• Growth Strategy: The company’s strategy includes broadening media advertising, acquiring complementary brands, and expanding into new international markets. These initiatives are aimed at driving growth and increasing profitability.
• Industry Outlook: Synergy CHC operates in the global nutritional supplement market, which is forecasted to grow at a CAGR of 9.3% from 2018 to 2028, according to industry research.

3. Risks and Uncertainties

The report details a comprehensive set of risk factors that could materially impact the company’s future performance and share price:

• Highly Competitive Industry: The company operates in a market with significant competition, including larger players with greater financial, technical, and marketing resources. Failure to compete effectively could materially and adversely affect sales and growth prospects.
• Consumer Trends and Product Innovation: The company faces risks related to shifting consumer preferences and the need for continuous innovation. Delays in product development or failure to meet market demand could hurt revenues and market position.
• Adverse Publicity: Negative publicity or regulatory actions related to product safety or business practices could damage the company’s reputation and sales.
• Execution of Strategic Initiatives: There is no guarantee that new strategies, including acquisitions, will be successful or deliver expected benefits. The pursuit of these initiatives could also pose significant costs and risks.
• International Expansion Risks: Entering new markets exposes the company to regulatory, legal, and operational challenges, including uncertainty in foreign laws and unexpected regulatory changes.
• Supply Chain and Raw Materials: Increases in the price or shortages of key raw materials could affect margins and profitability.
• Liquidity and Capital Raising: While the company currently has a working capital surplus and new capital raised, its ability to continue meeting obligations depends on future operational performance and access to financing. Additional capital raises (debt or equity) could dilute current shareholders or impose restrictive covenants.
• Internal Controls: Management identified material weaknesses in internal controls over financial reporting as of December 31, 2025. While remediation efforts are ongoing, failure to address these could result in restatements, regulatory actions, or loss of investor confidence—all of which could negatively impact the stock.

4. Shareholder-Specific Information

• Common Stock Information: The company’s common stock is listed on the Nasdaq Capital Market under the ticker SNYR. As of March 27, 2026, there were 11,303,853 shares outstanding.
• Dividends: The company has not paid dividends since inception and does not anticipate paying dividends in the foreseeable future. Earnings will be retained to fund operations and growth.
• Potential Dilution: Future issuances of common stock (for incentive plans, acquisitions, or under the ATM program) may dilute existing shareholders.
• Market Liquidity and Volatility: The trading volume for Synergy CHC shares has been historically limited. Share price could be volatile due to earnings fluctuations, strategic transactions, changes in management, regulatory actions, or broader market and economic conditions.

5. Human Capital Management

• As of December 31, 2025, Synergy CHC employed 28 full-time employees. The company emphasizes positive employer-employee relations and has no union contracts in place.
• The company invests in employee retention, health, wellness, and fair compensation practices to improve operational effectiveness and support long-term stakeholder value.

6. Legal and Regulatory Matters

• The company notes that changes in accounting standards, tax legislation, or increased regulatory scrutiny could materially impact its financial statements and operating costs.
• There are risks related to compliance with U.S. and international regulations, including those specific to the nutritional supplement industry.

7. Outlook and Guidance

• Management is focused on remediating internal control weaknesses, executing its growth strategy, and maintaining adequate liquidity.
• While the company believes it has sufficient resources to meet obligations for the next 12 months, continued operational and financial discipline will be necessary.

Conclusion: What Investors Should Watch

• The sharp swing from profit to a substantial net loss is significant and could pressure the share price unless the company can demonstrate a clear path to profitability.
• Execution risk around growth initiatives, remediating internal controls, and managing liquidity are critical for future performance.
• Any positive news on returning to profitability, successful acquisitions, or effective control remediation could drive the stock higher, while ongoing losses, dilution, or regulatory issues could weigh on the share price.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full SEC filings, conduct their own due diligence, and consult with their financial advisors before making investment decisions. The company’s performance is subject to a variety of risks and uncertainties as outlined above and in its official filings.

View Synergy CHC Corp. Historical chart here